BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Melanoma Institute Australia
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260430T170000
DTEND;TZID=Australia/Sydney:20260430T170000
DTSTAMP:20260430T173035
CREATED:20260303T011942Z
LAST-MODIFIED:20260303T011942Z
UID:10000266-1777568400-1777568400@melanoma.org.au
SUMMARY:NSW Translational Research Grants Scheme
DESCRIPTION:Funding research projects that translate into better patient outcomes\, health service delivery\, and population health and wellbeing \nThe Translational Research Grants Scheme aims to: \n\nfoster the generation of high-quality research that is directly relevant to clinical\, health service and population health practice in NSW\nenhance health and medical research capability and capacity within the NSW health system\nsupport projects that have the potential to be translated into policy and practice\, including research that can be generalised and scaled in other LHDs/SHNs across the state\nreduce the time from evidence generation to practice implementation.\n\nHost organisations must identify and engage relevant partners to support effective delivery of the research project and implementation of the outcomes in NSW. \nRound 10 NOW OPEN. \nKey Dates\nEOI due to Host Organisation: 30 April 2026\nFull application due to Host Organisation: 31 July 2026\nFull applications due to NSW Ministry of Health\, Office for Health and Medical Research: 28 August 2026\nSuccessful applicants notified: Late February 2027\nResearch begins: 1 July 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nsw-translational-research-grants/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NSW-Health-Translational-Research-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260430T170000
DTEND;TZID=Australia/Sydney:20260430T170000
DTSTAMP:20260430T173035
CREATED:20260303T004445Z
LAST-MODIFIED:20260303T004445Z
UID:10000264-1777568400-1777568400@melanoma.org.au
SUMMARY:Australian Melanoma Research Foundation Research Grants
DESCRIPTION:The AMRF will continue to support the next generation of melanoma researchers in Australia by providing research grants to post-graduate students and early career researchers. \nThe AMRF will fund research that contributes to the understanding and prevention of melanoma. The number of grants awarded in 2026 will depend on the quality of the applications and the funds requested. The AMRF will be selective in the research it supports. Any proposal to the Foundation for research funding will need to be contestable and show evidence of scientific merit within the national context. \nThe aim of the AMRF’s grants scheme is to support high quality research that is not fully funded through other grant schemes or from other sources.  AMRF funds are to be applied to offset the direct costs of the research. The proposed research may be part of an existing  research program.  However\, the application to the AMRF should be for a stand-alone component of that existing project. \nApplications for funding will be assessed against several of the following criteria: \n\nPublication history in melanoma (by the applicant and/or their supervisor)\nEvidence of scientific merit and clinical need within the national context\nProposed dissemination of research findings\nBroader impact on education and awareness of melanoma\n\nKey Dates\nEOIs close: 30 April 2026\nFull applications deadline: 25 May 2026\nSuccessful applicants announced: 15 June 2026\nFunds available: by 30 June 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/amrf-research-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/AMRF-Research-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260422T170000
DTEND;TZID=Australia/Sydney:20260422T170000
DTSTAMP:20260430T173035
CREATED:20251202T042630Z
LAST-MODIFIED:20251223T044802Z
UID:10000221-1776877200-1776877200@melanoma.org.au
SUMMARY:ARC Discovery Projects
DESCRIPTION:Discovery Projects for funding commencing in 2027 will be run in a two-stage application process\, commencing with an Expression of Interest (EOI). Shortlisted applicants will be invited to submit a full application. \nDiscovery Projects may be undertaken by individual researchers or research teams to: \n\nexpand knowledge base and research capacity in Australia\, and\neconomic\, commercial\, environmental\, social and/or cultural benefits for Australia.\n\nDiscovery Projects are for funding between $30\,000 and $500\,000 each year for up to 5 consecutive years. Project funding may be used for: \n\npersonnel\, for example\, research associates or assistants and technicians and stipends for higher degree by research students\nteaching relief\naccess to research and infrastructure facilities and technical workshop services\nessential field research\nexpert third party services\nequipment and consumables\npublication and dissemination of outputs and outreach\nspecialised computer equipment and software\ntravel costs essential to the project\nweb hosting and development\nworkshops\, focus groups and conferences\, and\nessential support costs for researchers who are carers or who personally require care or assistance.\n\nKey Dates\nEOI Close: 12 December 2025\nEOI Outcomes Announced: 25 February to 27 February 2026\nFull Application Open: 2 March 2026\nFull Application Close: 22 April 2026\nRejoinders: 23 June to 6 July 2026\nAnticipated announcement: 19 October to 30 October 2026 \nSEE GRANT GUIDELINES PDFSEE GRANT GUIDELINES CHANGES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/arc-discovery-projects/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/12/ARC-Discovery-Projects-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260409T170000
DTEND;TZID=Australia/Sydney:20260409T170000
DTSTAMP:20260430T173035
CREATED:20260203T031521Z
LAST-MODIFIED:20260203T031521Z
UID:10000244-1775754000-1775754000@melanoma.org.au
SUMMARY:ARC Linkage Infrastructure\, Equipment and Facilities
DESCRIPTION:The Linkage Infrastructure\, Equipment and Facilities (LIEF) scheme provides funding to eligible organisations for research infrastructure\, equipment and facilities. \nUnder this scheme researchers participate in cooperative initiatives so that expensive research infrastructure\, equipment and facilities can be shared between higher education organisations and industry. \nThe scheme fosters collaboration through its support of the cooperative use of international or national research facilities. \nApplicants may seek funding for: \n\ninfrastructure\, equipment and facility purchases\, construction and installation\nsalaries directly associated with creating and installing infrastructure\, equipment or facilities\nleasing of infrastructure\, equipment or facilities\nconsortium membership costs\, in the case of Australia’s participation in the use of significant international-scale or national research facilities\nspecialised computing facilities and software\ncompilations\, catalogues\, clearing houses or bibliographies.\n\nThis scheme is intended to support researchers from higher education organisations and industry to gain access to the infrastructure\, equipment and facilities that they need to carry out their research. The scheme provides funding to eligible organisations to purchase\, construct or access expensive research infrastructure. \nKey Dates \nApplications close: 9 April 2026 \nAnnouncement: 22 December 2026 – 16 March 2027 \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/arc-linkage-infra-equip/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/ARC-Linkage-Infra-Equip-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260401T170000
DTEND;TZID=Australia/Sydney:20260401T170000
DTSTAMP:20260430T173035
CREATED:20260203T035453Z
LAST-MODIFIED:20260203T035453Z
UID:10000248-1775062800-1775062800@melanoma.org.au
SUMMARY:NHMRC Synergy Grants
DESCRIPTION:Synergy Grants support outstanding multidisciplinary teams of investigators to work together to answer major questions that cannot be answered by a single investigator. \nThe intended outcomes of the Synergy Grant scheme are: \n\nmultidisciplinary research that addresses major problems in all areas of human health and medical research\, from discovery to translation\nhighly collaborative teams of diverse researchers including by gender\, career stage and cultural background\, working together to address major problems in human health.\n\nSynergy Grants may be funded by\, or in conjunction with\, other organisations. These grants offer opportunities to researchers whose work is relevant to the priorities and research interests of the partner organisations. \nKey Dates \nMinimum data: 4 March 2026 17:00 AEST \nApplications close: 1 April 2026 17:00 AEST \nOutcomes: October 2026 \nSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-synergy-grants/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/NHMRC-Synergy-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260401T170000
DTEND;TZID=Australia/Sydney:20260401T170000
DTSTAMP:20260430T173035
CREATED:20260203T034803Z
LAST-MODIFIED:20260204T042218Z
UID:10000247-1775062800-1775062800@melanoma.org.au
SUMMARY:MRFF 2025 Clinical Trials Activity
DESCRIPTION:The Medical Research Future Fund (MRFF) Clinical Trials Activity Initiative aims to: \n\nimprove the evidence base supporting clinical care\nhelp patients access trials relevant to their health circumstances\nenable researchers to bring international trials to Australian patients.\n\nThe Medical Research Future Fund (MRFF) – 2025 Clinical Trials Activity Grant Opportunity will support medical research and medical innovation projects that: \n\nStream 1 (Incubator): conduct a pilot study to assess the feasibility of a new clinical trial for one or more treatments and/or management strategies for a rare cancer\, rare disease and/or unmet need.\nStream 2 (Targeted Call for Research): conduct a clinical trial of one or more treatments and/or management-based interventions for rare cancers\, rare diseases and/or unmet need.\nStream 3 (Targeted Call for Research): conduct a clinical trial that supports the delivery of effective and high value care by targeting evidence gaps of value to health technology assessment processes in Australia.\nStream 4 (Targeted Call for Research): conduct a prevention clinical trial aimed at reducing the risk\, onset or progression of disease through early intervention strategies.\n\nThe intended outcome of the research is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality\, evidence-based and effective health care. \nThis grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health\, Disability and Ageing. \nKey Dates \nMinimum data due date: 4 March 2026 \nApplications close: 1 April 2026 \nFunding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-clinical-trials-activity/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/MRFF-2025-ClinicalT-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260331T235900
DTEND;TZID=Australia/Sydney:20260331T235900
DTSTAMP:20260430T173035
CREATED:20260203T024755Z
LAST-MODIFIED:20260203T024755Z
UID:10000249-1775001540-1775001540@melanoma.org.au
SUMMARY:The Viertel Charitable Foundation Fellowship
DESCRIPTION:The Sylvia & Charles Viertel Charitable Foundation invites applications for the Senior Medical Research Fellowships valued at $275\,000 per annum (total $1\,375\,000 over 5 years) to commence in 2027. \nThis funding opportunity is designed to support: \n\nearly to mid-career researchers qualified to at least the post-doctoral level (no more than 10 years post-doc\, taking into account career disruptions);\nwho are outstanding researchers;\nwho do not currently hold a senior research or teaching position;\nwho are medically qualified\, or PhD graduates of another scientific discipline with recognised post-doctoral achievements;\nwho are seeking to establish a research career in Australia and undertake research in an Australian academic institution; and\nwho are either an Australian citizen or permanent resident of Australia\, or a New Zealand citizen with a Special Category (subclass 444) visa.\n\nKey Dates \nApplications close: 31 March 2026 11:59pm (AEST) \nSEE GRANT GUIDELINES PDFAPPLY HERESEE WEBSITE
URL:https://melanoma.org.au/event/viertel-foundation-fellowship/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/The-Viertel-Charitable-Foundation-600-x-338-px-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260326T170000
DTEND;TZID=Australia/Sydney:20260326T170000
DTSTAMP:20260430T173035
CREATED:20260302T235556Z
LAST-MODIFIED:20260303T235853Z
UID:10000263-1774544400-1774544400@melanoma.org.au
SUMMARY:The Ian Potter Foundation Medical Research Program
DESCRIPTION:The Healthy pillar supports organisations that strive to provide innovative solutions to improve the health of all Australians. The Medical Research program aims to advance understanding and improve treatment of major diseases by supporting leading Australian research institutes\, universities and teaching hospitals in innovative biomedical research. \nIn the Medical Research program the Foundation will consider applications: \n\nTo support the provision of equipment and capital infrastructure to support outstanding research groups.\nThe minimum grant amount is $100\,000 (for a single instrument or piece of equipment) in this program area.\n\nKey Dates\nApplications close: Thursday 26 March 2026\, 5 pm AEDT\nGrants Announced: late June 2026 \nSEE GRANT CONDITIONSSEE WEBSITE
URL:https://melanoma.org.au/event/ian-potter-mrp/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/Ian_Potter_Foundation600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260320T170000
DTEND;TZID=Australia/Sydney:20260320T170000
DTSTAMP:20260430T173035
CREATED:20260106T033820Z
LAST-MODIFIED:20260107T084506Z
UID:10000227-1774026000-1774026000@melanoma.org.au
SUMMARY:Friends of the Mater 2026 Annual Grants
DESCRIPTION:The Friends of the Mater Foundation provides an annual grant funding program to support and enhance high quality patient care\, clinical practice\, research and education across the Mater Hospital campus. Foundation grants are available to medical clinicians\, nurses and allied health professionals at the Mater and will be awarded according to potential benefits to patient care outcomes. The amount of grant funding available each year is determined by the interest earnt on the Foundation’s capital. \nThe Friends of The Mater Foundation allocated grants to advance The Mater Hospital as a Centre of excellence in health services and to achieve the best healthcare outcomes for patients. \nGrants are awarded for equipment\, facilities\, research and clinical education programs. \nApplications are invited from medical clinicians\, nurses and allied health professionals across all departments of the Mater Hospital. \nKey Dates\nApplications close: Friday 20 March 2026\, 5.00pm AEDT \nSEE WEBSITE
URL:https://melanoma.org.au/event/fom-annual-grants-2026/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2025/12/Friends-Of-Mater-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260318T170000
DTEND;TZID=Australia/Sydney:20260318T170000
DTSTAMP:20260430T173035
CREATED:20260203T031044Z
LAST-MODIFIED:20260203T031044Z
UID:10000243-1773853200-1773853200@melanoma.org.au
SUMMARY:ARC Linkage Projects
DESCRIPTION:The Linkage Program promotes national and international research partnerships between researchers and business\, industry\, community organisations and other publicly funded research agencies. By supporting the development of partnerships\, the ARC encourages the transfer of skills\, knowledge and ideas as a basis for securing commercial and other benefits of research. \nThe Linkage Projects grant opportunity supports projects which initiate or develop long term strategic research alliances to apply advanced knowledge to problems\, acquire new knowledge and as a basis for securing commercial and other benefits of research. \nThere will be one assessment round for Linkage Projects 2026. \nThe Linkage Projects scheme objectives are to: \n\nsupport internationally competitive research projects and teams on challenges or opportunities of relevance to research end-users;\nfoster the establishment and strengthening of research alliances between higher education organisations and research end-users;\nenhance the scale and focus of research\, including in Australian Government priority areas.\n\nApplications for funding under the Linkage Projects scheme must include at least one Partner Organisation. The Partner Organisation must make a contribution in cash and/or in kind to the project. The combined Partner Organisation contributions for an application (i.e. the total of the cash and in-kind contributions of the Partner Organisations) must at least match the total funding requested from the ARC. \nThe Linkage Projects scheme provides project funding of $50\,000 to $300\,000 per year for two to five years. \nThis scheme is intended to support researchers from higher education organisations and industry to build partnerships with organisations\, to conduct research which will benefit the organisations and Australia. \nKey Dates \nApplications close: 18 March 2026 \nAnnouncement: 10 December 2026 to 9 March 2027 \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/arc-linkage-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/ARC-Linkage-Projects-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260311T170000
DTEND;TZID=Australia/Sydney:20260311T170000
DTSTAMP:20260430T173035
CREATED:20260203T030555Z
LAST-MODIFIED:20260203T030555Z
UID:10000242-1773248400-1773248400@melanoma.org.au
SUMMARY:ARC Discovery Early Career Researcher Award
DESCRIPTION:The DECRA scheme provides focused research support for early career researchers in both teaching and research\, and research-only positions. \nIt’s objectives are to: \n\nsupport outstanding early-career researchers with demonstrated capacity for high-quality research and emerging capability for leadership and supervision\nfoster collaboration\, with national or international researchers\nsupport excellent and innovative research that addresses a significant problem or gap in knowledge and represents value for money\ncreate new or advanced knowledge resulting from the outcomes of the research with economic\, commercial\, environmental\, social and/or cultural benefits for Australia\nadvance promising early career researchers and promote enhanced opportunities for diverse career pathways in high-quality and supportive environments.\n\nThe DECRA scheme provides funding for three-year DECRAs\, providing a researcher with salary and on-costs\, and up to $50\,000 per year in project costs. \nProject funding may be used for: \n\npersonnel\, postdoctoral research associates and research assistants\, technicians and laboratory attendants\naccess to research and infrastructure facilities and technical workshop services\nessential field research\nexpert third party services\nequipment and consumables\npublication and dissemination of project research outputs and outreach activities\nspecialised computer equipment and software\ntravel costs essential to the project for up to $50\,000 over the project activity period\nweb hosting and development\nworkshops\, focus groups and conferences\, and\nreasonable essential costs for researchers who are carers or who themselves require care.\n\nKey Dates \nApplications Close: 11 MARCH 2026 \nAnticipated Announcement: 10 December 2026 – 9 March 2027 \nSEE GRANT GUIDELINES PDFSEE GRANT GUIDELINES CHANGES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/arc-discovery-early-career/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/ARC-Discovery-Early-Career-Researcher-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260309T170000
DTEND;TZID=Australia/Sydney:20260309T170000
DTSTAMP:20260430T173035
CREATED:20260210T034150Z
LAST-MODIFIED:20260210T034150Z
UID:10000251-1773075600-1773075600@melanoma.org.au
SUMMARY:Sydney Cancer Partners SERCI Grant
DESCRIPTION:SCP Small Equipment and Research Capacity Building Infrastructure (SERCI) Grant \nThe objective is to support SCP members to complete internationally competitive translational cancer research projects by improving access to specialised research equipment or software. \nApplicants may request funds to purchase equipment\, software or software licenses with a total purchase cost of up to $50K (excluding GST). There is no minimum cost request. Equipment/software purchased under this scheme must be located and/or accessed at a Sydney Health Partners member institution. \nKey Dates \nScheme Open: 9 February 2026  \nScheme Close: 5 pm\, 9 March 2026 \nNotification of outcomes: 10 April 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/scp-serci-grant/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/Sydney_Cancer_Partners-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260309T170000
DTEND;TZID=Australia/Sydney:20260309T170000
DTSTAMP:20260430T173035
CREATED:20260203T032013Z
LAST-MODIFIED:20260203T032013Z
UID:10000246-1773075600-1773075600@melanoma.org.au
SUMMARY:Rising Tide Clinical Cancer Research Program
DESCRIPTION:RTFCCR invites academic institutions and not-for-profit organizations to collaborate on innovative\, patient-centered clinical trials. Our mission is to improve cancer patients’ treatment options and quality of life by funding studies focused on detection\, treatment\, and implementation. \nWe support phase I to phase III interventional clinical trials but do not fund basic research\, phase IV trials\, or observational studies. Funding is available to institutions worldwide where effective grant oversight is feasible. \nSubmission Criteria \n\nThe interventional clinical trial can be an early—to—late—stage clinical trial (Phase 1\, 2\, and 3) with a patient partner involvement in the study protocol design.\nOnly applications aimed at detecting and intervening in early cancer (pre-cancerous changes) can also be considered at the pre-clinical validation stage.\nPharmaceutical agents used in the study can be generic (off-patent repurposing)\, registered for this indication\, or under development by an academic institution.\nClinical trials testing immunotherapies should be discussed with RTFCCR before application submission.\nFinal selection will be contingent on scientific review\, strategic portfolio fit\, and availability of funds\n\nKey Dates \nApplication deadlines: 9 March\, 22 June and 23 November 2026 \nSEE FUNDING GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/rising-tide-research-program/
CATEGORIES:Grants,Clinical Trial Cohorts
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/RisingTide600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260306T235900
DTEND;TZID=Australia/Sydney:20260306T235900
DTSTAMP:20260430T173035
CREATED:20260211T233409Z
LAST-MODIFIED:20260211T233409Z
UID:10000254-1772841540-1772841540@melanoma.org.au
SUMMARY:CPC Catchlove Sylvan Mid-Career Researcher Fellowship
DESCRIPTION:Applications for the Charles Perkins Centre Catchlove Sylvan Mid-Career Researcher Fellowship 2026 are now open. Inaugurated in 2025\, this bridging support scheme is designed to help our best mid-career researchers remain in academia. \nThe Fellowship is made possible with generous support from our long-time friends\, philanthropists\, Dr Barry Catchlove and Professor Louise Sylvan. In its inaugural year\, the scheme supported three of our brightest mid-career researchers. \nIn 2026\, up to three awards\, with a maximum value of $100\,000 each\, will be available for Charles Perkins Centre mid-career researchers. \nKey Dates \nApplications close: Friday 6 March 2026 \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/cpc-catchlove-fellowship/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/Charles_Perkins_Centre-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260302T170000
DTEND;TZID=Australia/Sydney:20260302T170000
DTSTAMP:20260430T173035
CREATED:20260203T032740Z
LAST-MODIFIED:20260203T032740Z
UID:10000245-1772470800-1772470800@melanoma.org.au
SUMMARY:CRI Postdoctoral Fellowships
DESCRIPTION:CRI Irvington and CRI Immuno-Informatics Postdoctoral Fellowship Program  \nThe CRI Irvington Postdoctoral Fellowship Program is one of the most prestigious training opportunities in immunology and cancer immunology. It supports outstanding young researchers at the world’s leading universities and research institutions\, providing the resources\, mentorship\, and professional development needed to launch independent scientific careers at the forefront of discovery. \nThe CRI Immuno-Informatics Postdoctoral Fellowship Program supports outstanding early-career scientists worldwide who seek dual expertise in immunology and data science. This unique program fosters a new generation of researchers fluent in both biology and computation\, equipping them to drive innovation in cancer immunotherapy. \nFellowships provide three years of support\, including a stipend of $74\,000\, $76\,000\, and $78\,000 in years 1-3. The host institution receives a $5\,000 annual allowance for use at the sponsor’s discretion to cover costs such as research supplies\, conference travel\, health insurance\, or childcare. CRI also provides dedicated support for fellows to attend the CRI Bioinformatics Bootcamp. Deductions for administrative overhead are not allowed from either the stipend or the institutional allowance. \nKey Dates \nApplication deadlines: 2 March and 1 September 2026 \nSEE CRI IRVINGTON GUIDELINESSEE CRI IMMUNO-INFORMATICS GUIDELINES
URL:https://melanoma.org.au/event/cri-postdoc-fellowships/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/CRI-PostDoc-Fellow-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260227T170000
DTEND;TZID=Australia/Sydney:20260227T170000
DTSTAMP:20260430T173035
CREATED:20260211T024951Z
LAST-MODIFIED:20260211T024951Z
UID:10000252-1772211600-1772211600@melanoma.org.au
SUMMARY:Sydney Cancer Partners Conference & Travel Funding
DESCRIPTION:SCP has limited funding available to support members presenting research results at a national or international conference. \nThis scheme aims to: \n\nSupport the professional development and expand the knowledge of SCP members.\nBuild interest and expertise in translational cancer research and evidence based clinical practice.\nDisseminate knowledge and information through the SCP website and other events.\n\nSuccessful applicants will receive up to: \n\n$1\,000 to present in person at a conference within Australia.\n$4\,000 to present in person at an international conference.\n$500 for registration fees to present at a virtual conference.\n\nFunding for in-person events can be used for registration fees\, travel\, and reasonable accommodation expenses. Per diem and meal reimbursement is not a claimable expense. Awardees are required to submit original invoices or receipts for reimbursement. \nFunding for virtual conferences is limited to the registration fee. \nKey Dates \nRound 16: 1 April – 30 June 2026. Applications close 5pm\, 27 February 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/scp-conference-travel-funding/
CATEGORIES:Grants,Travel
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/02/Sydney_Cancer_Partners600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260227T170000
DTEND;TZID=Australia/Sydney:20260227T170000
DTSTAMP:20260430T173035
CREATED:20251202T040717Z
LAST-MODIFIED:20251202T042314Z
UID:10000222-1772211600-1772211600@melanoma.org.au
SUMMARY:Sally Crossing AM Award for an Outstanding Outcome in Cancer Research
DESCRIPTION:This Award is dedicated to the memory of the late Sally Crossing AM (1946-2016). Sally was a pioneer and tireless advocate for consumer involvement in cancer research. Cancer Council NSW and Cancer Voices NSW acknowledge the extraordinary support of the Belalberi Foundation and the Crossing family in conferring this award. \nThe Sally Crossing AM Award for an Outstanding Outcome in Cancer Research (individual award) rewards outstanding achievement in cancer research\, the inclusion of consumers in research\, and the delivery of significant benefit to the cancer community. \nThe Award recipient will receive $75\,000 to further their research endeavours. \nKey Dates\nApplications close: Friday 27 February 2026\, 5.00pm AEDT \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/sally-crossing-award/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/12/CC-Sally-Crossing.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20251211T170000
DTEND;TZID=Australia/Sydney:20251211T170000
DTSTAMP:20260430T173035
CREATED:20251202T032647Z
LAST-MODIFIED:20251202T032844Z
UID:10000220-1765472400-1765472400@melanoma.org.au
SUMMARY:MRFF 2025 Research Data Infrastructure Grant
DESCRIPTION:This grant opportunity is part of the Medical Research Future Fund and the Research Data Infrastructure Initiative. It looks to fund the creation or extension of national research data infrastructure to support world-class health and medical research in Australia. \nThe objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that use novel methods to harness multiple existing data infrastructure types in developing and implementing new approaches for addressing an unmet medical need. \nKey Dates\nApplications close: Thursday 11 December 2025\, 5.00pm AEDT \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-2025-data-infrastructure-grant/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/11/MRFF.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20251205T170000
DTEND;TZID=Australia/Sydney:20251205T170000
DTSTAMP:20260430T173035
CREATED:20251118T004913Z
LAST-MODIFIED:20251203T015911Z
UID:10000211-1764954000-1764954000@melanoma.org.au
SUMMARY:Perpetual Impact Grant
DESCRIPTION:The Perpetual IMPACT Philanthropy Application program creates meaningful connections between philanthropists and Not-for-Profit (NFP) organisations. It provides a platform for NFP’s to showcase how they deliver improved outcomes for the communities they serve. \nThe grant supports high-quality\, sustainable impact by identifying organisations that demonstrate strong governance\, capable leadership\, strategic clarity\, and a clear focus on measurable outcomes. \nKey Dates\nApplications open: Monday 27 October 2025\, 9.00am AEDT\nApplications close: Friday 5 December 2025\, 5.00pm AEDT \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/perpetual-impact-grant/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/11/Perpetual-1.png
END:VEVENT
END:VCALENDAR